An Analysis of High-risk Factors for Immune Checkpoint Inhibitor-related Adverse Reactions in Patients with Lung Cancer

HUANG Aiben, LIU Jia, PANG Li, SUN Jie, XIE Mei, CHEN Xiaolan, QIAN Jin, JIANG Hong, SUN Yue, XUE Xinying, PAN Lei

PDF(987 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(987 KB)
Labeled Immunoassays and Clinical Medicine ›› 2025, Vol. 32 ›› Issue (3) : 460-465. DOI: 10.11748/bjmy.issn.1006-1703.2025.03.004
Clinical Investigation

An Analysis of High-risk Factors for Immune Checkpoint Inhibitor-related Adverse Reactions in Patients with Lung Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 32(3): 460-465 https://doi.org/10.11748/bjmy.issn.1006-1703.2025.03.004

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(987 KB)

Accesses

Citation

Detail

Sections
Recommended

/